NFKB1 and breast cancer: One of them is that because Bfl-1 is constitutively ubiquitinized at its C-terminal region and processed by proteasomal degradation, BC might function as a kind of competitive inhibitor of proteasome, thereby leading to NF-κB suppression and cell death.